News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement Todd Neale December 09, 2022
News Daily News Meth-Related HF: Challenges at the Intersection of CVD and Addiction Caitlin E. Cox December 06, 2022
News Daily News Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases Todd Neale December 06, 2022
News Daily News Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms Shelley Wood November 23, 2022
News Daily News AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG Todd Neale November 17, 2022
News Daily News Most Patient-Reported Outcome Measures in CVD Fall Short L.A. McKeown September 23, 2022
News Daily News Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM Todd Neale September 15, 2022
News Daily News Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive Michael O'Riordan September 09, 2022
News Daily News Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients Caitlin E. Cox August 22, 2022
News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022
News Daily News ‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19 L.A. McKeown August 10, 2022
News Daily News Early LV Recovery After TAVI Points to Better 5-Year Survival Yael L. Maxwell August 01, 2022
News Daily News Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients Caitlin E. Cox July 13, 2022
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Daily News Grieving a Loved One Increases Mortality Risk in HF Patients L.A. McKeown July 06, 2022
News Daily News Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women Yael L. Maxwell June 03, 2022
News Daily News Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis Caitlin E. Cox May 03, 2022
News Daily News FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy Michael O'Riordan April 29, 2022